Daniel Brian Nichols

850 total citations
18 papers, 701 citations indexed

About

Daniel Brian Nichols is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Daniel Brian Nichols has authored 18 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Molecular Biology and 6 papers in Virology. Recurrent topics in Daniel Brian Nichols's work include Hepatitis C virus research (5 papers), Poxvirus research and outbreaks (5 papers) and interferon and immune responses (4 papers). Daniel Brian Nichols is often cited by papers focused on Hepatitis C virus research (5 papers), Poxvirus research and outbreaks (5 papers) and interferon and immune responses (4 papers). Daniel Brian Nichols collaborates with scholars based in United States, Türkiye and Italy. Daniel Brian Nichols's co-authors include Susan C. Baker, Joanna L. Shisler, Zhongbin Chen, Bridget S. Banach, Yu-Dong Yang, Yaling Xing, Yang Zheng, Xiaojuan Chen, Li Sun and Kui Li and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Virology.

In The Last Decade

Daniel Brian Nichols

17 papers receiving 686 citations

Peers

Daniel Brian Nichols
Shin-ichiro Hattori Japan
Alexej Dick United States
Justin Shields Canada
Susan L. Binford United States
Jinkui Niu United States
Jun Takayama Japan
Dongrong Yi China
Robert N. Kirchdoerfer United States
Jyh‐Haur Chern Taiwan
Kevin R. Alliston United States
Shin-ichiro Hattori Japan
Daniel Brian Nichols
Citations per year, relative to Daniel Brian Nichols Daniel Brian Nichols (= 1×) peers Shin-ichiro Hattori

Countries citing papers authored by Daniel Brian Nichols

Since Specialization
Citations

This map shows the geographic impact of Daniel Brian Nichols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Brian Nichols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Brian Nichols more than expected).

Fields of papers citing papers by Daniel Brian Nichols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Brian Nichols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Brian Nichols. The network helps show where Daniel Brian Nichols may publish in the future.

Co-authorship network of co-authors of Daniel Brian Nichols

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Brian Nichols. A scholar is included among the top collaborators of Daniel Brian Nichols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Brian Nichols. Daniel Brian Nichols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hill, Erik R., et al.. (2023). The MC160 protein of the molluscum contagiosum virus dampens cGAS/STING-induced interferon-β activation. Experimental and Molecular Pathology. 134. 104876–104876.
2.
Nichols, Daniel Brian, et al.. (2021). Educating ethically during COVID-19. PubMed Central. 6(1). 177–193. 3 indexed citations
3.
Coutu, Jesse, et al.. (2019). The Molluscum Contagiosum Virus Protein MC163 Inhibits TNF-α-induced NF-κB Activation. Future Virology. 14(5). 319–333. 1 indexed citations
4.
5.
Arora, Payal, Amartya Basu, Marianne Schmidt, et al.. (2017). Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication. Hepatology. 65(5). 1462–1477. 3 indexed citations
6.
7.
Fernandes, Talita de A., Dinesh Manvar, Amartya Basu, et al.. (2016). 5-Carba-pterocarpens: A new scaffold with anti-HCV activity. European Journal of Medicinal Chemistry. 112. 33–38. 7 indexed citations
8.
Deng, Xufang, Sudhakar Agnihothram, Anna M. Mielech, et al.. (2014). A Chimeric Virus-Mouse Model System for Evaluating the Function and Inhibition of Papain-Like Proteases of Emerging Coronaviruses. Journal of Virology. 88(20). 11825–11833. 15 indexed citations
9.
Küçükgüzel, İlkay, Amartya Basu, Esra Tatar, et al.. (2013). 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase. European Journal of Medicinal Chemistry. 69. 931–941. 41 indexed citations
10.
Tatar, Esra, İlkay Küçükgüzel, Fikrettin Şahιn, et al.. (2013). Synthesis and characterization of flurbiprofen hydrazide derivatives as potential anti-HCV, anticancer and antimicrobial agents. Medicinal Chemistry Research. 22(12). 5685–5699. 30 indexed citations
11.
Nichols, Daniel Brian, Raquel A. C. Leão, Amartya Basu, et al.. (2013). Evaluation of Coumarin and Neoflavone Derivatives as HCV NS5B Polymerase Inhibitors. Chemical Biology & Drug Design. 81(5). 607–614. 20 indexed citations
12.
Golub, Andriy G., Amartya Basu, Volodymyr G. Bdzhola, et al.. (2012). Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors. European Journal of Medicinal Chemistry. 58. 258–264. 15 indexed citations
13.
Sun, Li, Yaling Xing, Xiaojuan Chen, et al.. (2012). Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Signaling. PLoS ONE. 7(2). e30802–e30802. 227 indexed citations
14.
Nichols, Daniel Brian, Guy Fournet, Amartya Basu, et al.. (2012). Inhibition of hepatitis C virus NS5B polymerase by S-trityl-l-cysteine derivatives. European Journal of Medicinal Chemistry. 49. 191–199. 19 indexed citations
15.
Ghosh, Arun K., Jun Takayama, Kalapala Venkateswara Rao, et al.. (2010). Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein−Ligand X-ray Structure and Biological Evaluation. Journal of Medicinal Chemistry. 53(13). 4968–4979. 122 indexed citations
16.
Ghosh, Arun K., Jun Takayama, Kiira Ratia, et al.. (2009). Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease. Journal of Medicinal Chemistry. 52(16). 5228–5240. 109 indexed citations
17.
Nichols, Daniel Brian & Joanna L. Shisler. (2009). Poxvirus MC160 Protein Utilizes Multiple Mechanisms To Inhibit NF-κB Activation Mediated via Components of the Tumor Necrosis Factor Receptor 1 Signal Transduction Pathway. Journal of Virology. 83(7). 3162–3174. 31 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin-ichiro Hattori Breakdown of academic impact, for papers by Alexej Dick Breakdown of academic impact, for papers by Justin Shields Breakdown of academic impact, for papers by Susan L. Binford Breakdown of academic impact, for papers by Jinkui Niu Breakdown of academic impact, for papers by Jun Takayama Breakdown of academic impact, for papers by Dongrong Yi Breakdown of academic impact, for papers by Robert N. Kirchdoerfer Breakdown of academic impact, for papers by Jyh‐Haur Chern Breakdown of academic impact, for papers by Kevin R. Alliston
Rankless by CCL
2026